Literature DB >> 9830088

Field performance measurements of half-facepiece respirators: developing probability estimates to evaluate the adequacy of an APF of 10.

W R Myers1, Z Zhuang.   

Abstract

To evaluate the protection provided by negative-pressure, half-facepiece respirators, ambient and in-facepiece samples were collected on workers in foundry, aircraft-painting, and steel-manufacturing operations. Protection was assessed by workplace protection factors (WPF). The appropriateness of the assigned protection factor (APF) for half-facepiece respirators was evaluated with a new approach using the WPF data from these and other studies previously published. The new approach utilizes binomial statistics based on the number of successes (no overexposure) and failures (overexposure) and is illustrated with a graphical representation of WPF data. With this consideration of the data, the probability of overexposure occurring during a wearing period for workers wearing the half-facepiece respirators represented by the studies referenced here was 0.5%, with a 95% confidence interval of 0.01 to 2.7%. If 50% in-facepiece sampling errors are considered, the probability of overexposure was 2.9%, with a 95% confidence interval of 1.1 to 6.3%. The authors believe the current APF of 10 for half-facepiece respirators is appropriate.

Mesh:

Substances:

Year:  1998        PMID: 9830088     DOI: 10.1080/15428119891010983

Source DB:  PubMed          Journal:  Am Ind Hyg Assoc J        ISSN: 0002-8894


  2 in total

1.  Using CO(2) to determine inhaled contaminant volumes and blower effectiveness in several types of respirators.

Authors:  Arthur T Johnson; Frank C Koh; William H Scott; Timothy E Rehak
Journal:  J Environ Public Health       Date:  2011-07-18

2.  Comparison of fit factors among healthcare providers working in the Emergency Department Center before and after training with three types of N95 and higher filter respirators.

Authors:  Hongjung Kim; Juncheol Lee; Sanghyun Lee; Jaehoon Oh; Boseung Kang; Tae Ho Lim; Hyunggoo Kang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.